Provided By Globe Newswire
Last update: Jun 15, 2022
Bernards is internationally recognized for his contributions to the development of effective anti-cancer drugs from their earliest stages through clinical use
NASDAQ:LIXT (11/7/2025, 8:00:02 PM)
4.25
-0.04 (-0.93%)
Find more stocks in the Stock Screener


